Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Win-Win Biotechnology is a Taiwan-based life science company specializing in the research, development, and large-scale fermentation of medicinal mushrooms, primarily Antrodia cinnamomea and Cordyceps sinensis. Established in 2012, the company utilizes advanced proprietary solid-state and liquid-state fermentation technologies to produce standardized bioactive compounds for use in nutraceuticals, functional foods, and as therapeutic adjuvants. Win-Win Biotechnology focuses on providing high-purity ingredients such as triterpenoids and polysaccharides, which are marketed for liver protection, immune enhancement, and support during cancer treatment. The company is known for its collaboration with academic institutions to clinically validate the efficacy and safety of its fungal extracts. With a production facility in Tainan and operations in Hong Kong, Win-Win Biotechnology serves a global market of health supplement manufacturers and wellness providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Win-Win Biotechnology.